3.43 (-%)
As of Nov 21, 2024
Source:
Polypid Ltd. is a Phase 3 clinical-stage biopharmaceutical company focused on developing targeted, locally administered and prolonged-release therapeutics using our proprietary PLEX technology.
| Country | ISRAEL |
| Headquarters | petach tikva, israel |
| Phone Number | (908) 858-5995 |
| Industry | manufacturing |
| CEO | Dikla Czaczkes Akselbrad |
| Website | www.polypid.com |